“…In many cancer forms, such as breast [14, 15], lung [16], brain [17], urological [18, 19], malignant melanoma [20], pheochromocytoma [21], cholangiocarcinoma [22] and adipocytic tumors [23], a high tenascin-C expression has been correlated with a poor patient survival [5, 6]. While this correlation applies to some cancers, there are also reports where tenascin-C expression correlates with a lower stage of disease and a better patient outcome [5, 6, 24, 25].…”